The demand for rx/reimbursement adult incontinence in Brazil is often related to the government programme Fármacia Popular. This programme aims to facilitate the supply of medicine and adult incontinence products in partnership with drugstores and basic healthcare units in the country.
The Brazilian population is set to continue ageing over the forecast period, with the share of consumers aged 65+ years set to reach 12% by 2027, up from 10% in 2022, according to Euromonitor International’s Economies and Consumers annual data. Moreover, the social inequality among the Brazilian population increases the need for government assistance programmes such as Farmácia Popular, which is predicted to be a positive growth driver for rx/reimbursement adult incontinence over the forecast period.
Within the Farmácia Popular programme rules, beneficiaries should be above 60 years of age or included under the group of people with disabilities. Consumers can purchase up to 40 units each time and after every 10 days with a discount of up to 90%, due a government subsidy.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Rx/Reimbursement adult incontinence industry in Brazil with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Brazil, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
To qualify for reimbursement, typically a note from a physician is required (a “prescription”) indicating that the patient is in need of incontinence supplies. Depending on the local system in place, supplies are then either shipped directly to consumer home by a designated service or a consumer has to pick up products at a pharmacy. Please be advised that services and routes to consumers can vary even within the same country and vary by state/region. Some countries provide reimbursement through income tax deductions. If this is the case in your market, we EXCLUDE this type of reimbursement from our Rx/Reimbursement coverage as it would be impossible to track. Additionally, consumers would have already purchased the products in retail before claiming tax deductions, and as such the products have already been counted as retail sales. The same logic applies to institutional sales. If a nursing home purchased adult incontinence products from a distributor/manufacturer for distribution to its patients/residents, these products would be included as AFH adult incontinence in our coverage, even though sometimes patients might claim healthcare deductions for costs of stay at a nursing home.
See All of Our DefinitionsThis report originates from Passport, our Rx/Reimbursement adult incontinence research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!